Herpes Zoster Ophthalmicus: Shingles in the Eye
What Is Herpes Zoster Ophthalmicus?
HZO occurs when the same virus that causes chickenpox reactivates inside a nerve that serves the forehead, upper eyelid, and eye. Understanding what triggers this condition and who is most vulnerable helps explain why early care is so important.
HZO is shingles that involves the eye and surrounding skin. After a person recovers from chickenpox, the varicella-zoster virus does not leave the body. It stays dormant inside the nerves, sometimes for decades. When it reactivates, it travels along the trigeminal nerve, specifically the branch that supplies the forehead, upper eyelid, the tip of the nose, and the eye itself.
The immune system normally keeps the dormant virus under control. As people age, that immune control can weaken. Stress, other illnesses, and medications that suppress the immune system can also allow the virus to reawaken and travel back down the nerve toward the skin and eye.
HZO accounts for roughly 10 to 20 percent of all shingles cases. Anyone who has ever had chickenpox carries the virus and is at some level of risk. The rate of shingles rises sharply after age 50. People who take immune-suppressing medications after organ transplants or for autoimmune conditions are also at elevated risk.
HZO is not only a skin rash. The virus can inflame the cornea (the clear dome at the front of the eye), the iris (the colored part of the eye), the drainage system, and even the retina at the back of the eye. Starting antiviral treatment early shortens the active phase, lowers the risk of lasting eye damage, and reduces the chance of long-term nerve pain.
Signs and Symptoms of HZO
HZO typically unfolds in stages, beginning with vague warning signs before the rash appears. Knowing what to look for at each stage helps patients seek care at the right time.
Before any rash appears, many people feel pain, burning, or tingling on one side of the forehead or around the eye. The skin in that area may feel tender to the touch. Headache, low-grade fever, and fatigue can also occur around this time. These early signs are easy to mistake for a common headache or a minor viral illness.
Within a few days, a rash appears as red patches that develop into clusters of small fluid-filled blisters. The rash follows one side of the forehead, the upper eyelid, and sometimes the tip or side of the nose. It stops at the midline of the face and does not cross to the other side. Over several days, the blisters crust over and gradually heal.
When blisters appear on the tip or side of the nose, this is called Hutchinson sign. It is an important warning because the nerve branch that serves the nose also serves key structures inside the eye. The presence of Hutchinson sign increases the risk of corneal inflammation, iritis, and other serious eye complications. Any patient with this finding should have a prompt eye exam the same day.
Eye-related symptoms include redness, tearing, pain, blurred vision, and sensitivity to light. Some people notice a gritty or scratchy sensation in the eye. The eyelid may swell and become difficult to open. In more severe cases, the cornea can become cloudy. These symptoms may start at the same time as the rash or appear weeks later.
Postherpetic neuralgia is burning or stabbing nerve pain that persists for more than 90 days after the rash first appeared. A meaningful portion of HZO patients go on to develop this complication, and older age is the strongest risk factor. The pain can disrupt sleep, affect mood, and limit daily activity. Managing it often requires guidance from both an eye care provider and a pain specialist.
Eye Conditions HZO Can Cause
HZO can affect nearly every part of the eye, from the eyelid surface to the retina at the back. Some complications appear during the active rash phase, while others develop weeks or months later.
Blepharitis, which is inflammation along the eyelid margins, is a common early complication. Blisters on the lid can leave scarring along the lid margin. Conjunctivitis, which is redness and irritation of the clear membrane covering the white of the eye, also occurs frequently. These problems often improve as the rash heals but may require lubricating drops and lid hygiene for several weeks.
HZO can cause several forms of corneal inflammation. Early in the infection, fine branching sores may form on the corneal surface. Later, deeper inflammation can produce cloudy patches within the cornea tissue itself. A slower type of inflammation called disciform keratitis can appear weeks or even months after the rash has cleared, requiring continued monitoring.
HZO can damage the nerves that supply the cornea. When those nerves are weakened, the eye loses its ability to sense dryness or minor injury, a condition called neurotrophic keratopathy. Without this protective sensation, the corneal surface can break down without obvious warning signs. This complication can develop late, sometimes months after the initial episode, and requires ongoing care to prevent vision loss.
Anterior uveitis, commonly called iritis, is inflammation inside the front chamber of the eye. It causes aching pain, redness, and significant light sensitivity. HZO can also inflame the eye's drainage system, causing eye pressure to rise. Elevated eye pressure, if left untreated, can damage the optic nerve over time.
In rare but serious cases, HZO can reach the back of the eye. Acute retinal necrosis is a severe, rapidly progressing form of retinal inflammation that can cause sudden blurred vision, floaters, and vision loss. HZO can also affect the nerves that control eye movement, leading to double vision. These back-of-eye complications are uncommon but require immediate attention.
How HZO Is Diagnosed
Most cases of HZO can be identified through a careful examination of the rash and a thorough eye evaluation. Additional testing may be needed in less straightforward presentations.
The diagnosis is usually made by examining the rash pattern and performing a detailed eye exam. The rash following one side of the forehead, upper lid, and nose along the path of the V1 nerve branch is a key indicator. The eye exam evaluates the lids, corneal surface, iris, eye pressure, and the back of the eye. In typical cases, this examination is sufficient to confirm the diagnosis.
Lab testing is not required in most cases but becomes useful when the rash is atypical, very mild, or absent. PCR testing, which detects viral genetic material, can be performed on blister fluid, corneal scrapings, or fluid from inside the eye. This testing is most commonly used when the diagnosis is uncertain or when deeper inflammation has no clear cause.
An eye care provider may gently test whether the cornea can sense touch. A reduced response indicates nerve damage and raises the risk of neurotrophic disease. Patients with diminished corneal sensation need closer follow-up and more aggressive surface lubrication to protect the eye from undetected injury.
Eye pressure is measured at every visit because HZO can raise it without causing noticeable symptoms. Elevated pressure may silently damage the optic nerve if not identified and treated promptly. Regular pressure checks during and after an HZO episode are essential, and some patients require pressure-lowering drops for weeks or months.
A dilated exam allows a full view of the retina and optic nerve. This is used to detect uncommon but serious complications such as retinal inflammation. Any sudden drop in vision, new floaters, or flashes of light in a patient with HZO should be treated as an emergency requiring a same-day retinal evaluation.
Treatment Options for HZO
Treatment for HZO is most effective when started early. The approach depends on which parts of the eye are affected and how severe the involvement is.
Oral antiviral pills are the foundation of HZO treatment. Commonly used options include acyclovir at 800 mg five times daily, valacyclovir at 1 gram three times daily, or famciclovir at 500 mg three times daily, each taken for approximately seven days. Starting treatment within 72 hours of rash onset is strongly associated with a shorter active phase, a lower risk of eye complications, and a reduced chance of long-term nerve pain.
Topical steroid drops are prescribed for corneal stromal inflammation, iritis, and immune-related eye inflammation. These drops are typically tapered slowly over several weeks. Lubricating drops help protect the corneal surface, and a bandage contact lens may be used to support healing in fragile cases. Topical antiviral drops or gel may be added for active viral disease on the surface of the eye in selected situations.
When HZO raises eye pressure, pressure-lowering drops are started right away. In most patients, the pressure elevation is temporary and the drops can be gradually discontinued as the inflammation resolves. Some patients need longer treatment. Consistent follow-up with pressure monitoring is essential to guide safe tapering of these medications.
Postherpetic neuralgia does not always respond to standard pain relievers. Oral medications used for nerve pain, such as gabapentin and certain tricyclic antidepressants, are commonly prescribed and often provide meaningful relief. Topical patches containing lidocaine or capsaicin can provide additional comfort. When pain is severe or persistent, a pain specialist may become part of the care team. Starting antiviral therapy promptly reduces the likelihood of this complication but does not eliminate it entirely.
Some patients experience repeated flares of HZO-related corneal inflammation or iritis after the initial episode. Clinical evidence from a large multi-center study called the Zoster Eye Disease Study supports the use of long-term low-dose valacyclovir to reduce the rate of recurrent eye complications in patients with a history of HZO eye disease. An eye care provider can review whether this approach is appropriate for an individual patient's history.
When corneal damage is extensive or has not responded to drops, additional interventions may be needed. A bandage contact lens can protect a fragile corneal surface. Amniotic membrane grafts, which use tissue that supports healing, can help persistent surface defects close. In cases where scarring significantly impairs vision, corneal transplant surgery may be considered. These measures are reserved for the most severe cases and are typically performed after the active virus is under control.
Prevention and the Shingles Vaccine
Vaccination is the most reliable tool available for preventing HZO and its complications. Reducing other risk factors also plays a meaningful role in long-term eye protection.
The recombinant shingles vaccine is the primary preventive measure against shingles and HZO. Current guidelines recommend it for adults aged 50 and older and for adults aged 19 and older with a weakened immune system. It is given as two doses separated by two to six months. In the years following vaccination, reported efficacy against shingles and its associated nerve pain has been approximately 90 percent.
Getting vaccinated significantly lowers the chance of ever developing HZO. If shingles does occur after vaccination, cases tend to be milder and shorter in duration. A milder episode means a lower risk of corneal scarring, iritis, neurotrophic damage, and long-term nerve pain. For adults over 50 and those with weakened immune systems, this vaccine is one of the clearest steps available to preserve long-term eye health.
Good general health supports the immune system's ability to keep the dormant virus in check. Consistent sleep, balanced nutrition, and steady management of chronic medical conditions all contribute. Patients taking immune-suppressing medications should discuss vaccine timing with both their primary care provider and their specialist before receiving the shingles vaccine.
HZO does not spread from person to person as shingles. However, the fluid inside active blisters contains live virus that can cause chickenpox in someone who has never been infected or vaccinated. Active blisters should be kept covered. Close contact with newborns, pregnant people without prior chickenpox or vaccination, and people with weakened immune systems should be avoided until all blisters have fully crusted over.
Outlook and Long-Term Eye Care
Most people who receive timely treatment for HZO recover well. However, the condition can have lasting effects that require ongoing attention from an eye care provider.
The skin rash typically crusts over within one to two weeks. Acute pain and active viral symptoms usually settle within a few weeks after that. However, eye complications can emerge later. Surface disease, corneal inflammation, and iritis can appear or recur weeks to months after the rash has healed, making long-term follow-up a critical part of HZO care.
Most patients who receive early antiviral treatment return to their baseline vision. Some individuals develop lasting corneal scarring, neurotrophic damage, or recurrent iritis that affect vision over the long term. Consistent eye care and proactive surface protection can limit these effects. A smaller number of patients may ultimately need procedures or corneal surgery to restore functional vision.
Contact an eye care provider the same day if you notice a new blistering rash on one side of the forehead, upper eyelid, or nose. This is especially urgent if you also have eye pain, redness, blurred vision, or sensitivity to light. Antiviral treatment is most effective when started within 72 hours of rash onset. Sudden vision loss, new floaters, or flashes of light during or after an HZO episode should also be treated as an emergency.
Regular eye exams for several months after the rash clears are an essential part of HZO management. Follow-up visits allow monitoring of the cornea, iris, and eye pressure, as well as detection of nerve damage. Patients with a history of HZO eye disease may need ongoing yearly check-ins, since inflammation and surface problems can recur long after the original episode.
Frequently Asked Questions
These answers address practical questions that often arise after an HZO diagnosis and are intended to help guide decisions alongside care from your eye provider.
Driving safety depends on the degree of eye involvement. If vision is blurry, light sensitivity is severe, or eye pain is significant, driving is not safe and should be avoided until symptoms improve. Many patients take a short period away from driving during the most acute phase. Your eye care provider can give you a clear recommendation based on your specific exam findings and current vision.
A full repeat HZO episode in the same eye region is less common than the original episode, but it is possible. More frequently, patients experience recurrent flares of corneal inflammation or iritis tied to the original infection, sometimes months or years later. This is one reason why regular follow-up remains important even after the skin and initial symptoms have fully resolved. Early detection of a recurrent flare allows treatment before significant damage occurs.
Yes. A prior shingles episode does not reliably protect against a future one, and recurrent eye complications are a real concern. Current guidelines support receiving the recombinant shingles vaccine after a full recovery from an acute episode, once pain and rash have completely resolved. Your primary care provider can help determine the right timing. Getting vaccinated after a prior episode may reduce the risk of recurrence and future eye complications.
Some patients notice mild changes in skin pigmentation or small scars where blisters were most active. Starting antiviral treatment early and caring gently for the skin during healing helps minimize these effects. Picking or scratching at blisters significantly increases the risk of permanent scarring. If skin changes are a concern after full healing, a dermatologist can advise on longer-term skin care options.
Most patients do not. A standard course of antiviral medication at the start of the rash is usually sufficient. Long-term low-dose antiviral therapy is generally reserved for patients who experience repeated flares of corneal inflammation or iritis after the initial episode. If you are in this group, your eye care provider can walk you through the evidence and help you weigh the benefits and considerations for your specific situation.
It is best to wait until the rash has fully crusted over and the skin has completely healed before applying any eye makeup. Applying products too early can irritate sensitive skin and increase infection risk. When you do resume wearing makeup, use freshly opened products and clean applicators to avoid introducing bacteria to the healing area. If you are still experiencing active eye symptoms such as redness or discharge, wait for clearance from your eye care provider first.
Visit Us for Expert HZO Care
At Associated Eye Physicians & Surgeons, our team is experienced in diagnosing and managing herpes zoster ophthalmicus at every stage, from the first signs of the rash to long-term follow-up care. We understand how quickly this condition can progress and how much is at stake for your vision and comfort. Our offices across New Jersey are available to see urgent cases promptly, so you do not have to wait when it matters most. If you have any concern about shingles near the eye, we encourage you to reach out to our team right away.
My appointment was on time and very efficient. Everyone was friendly and took the time to answer my questions.
William Newcomb
Everyone was helpful and courteous. I always recommend this practice to persons looking for an excellent eye care.
Benedict Emanuele
Very nice staff and the doctor was excellent. He took his time to see and speak to my mom. First visit was great!
Ricardo H.
Took me on short notice and treated my infection, performed an exam and started a glaucoma treatment plan.
Eugene Sforza
Dr. Tchorbajian is exceptional and thorough with his exam. He made me feel at ease. The office is clean, and the staff friendly.Everyone is practicing social distancing. Careful control of the office. Hand sanitizers everywhere. I highly recommend.
Diane Haroutunian